A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome

NCT ID: NCT03931785

Last Updated: 2021-03-12

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

515 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-01

Study Completion Date

2020-03-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the safety and tolerability, treatment effect on abdominal pain, and dose response of MD-7246 administered orally to patients with diarrhea-predominant irritable bowel syndrome (IBS-D).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

MD-7246 300 μg

1 MD-7246 300-μg oral tablet and 3 matching placebo oral tablets

Group Type EXPERIMENTAL

MD-7246

Intervention Type DRUG

Oral tablet

Placebo

Intervention Type DRUG

Matching oral tablet

MD-7246 600 μg

2 MD-7246 300-μg oral tablets and 2 matching placebo oral tablets

Group Type EXPERIMENTAL

MD-7246

Intervention Type DRUG

Oral tablet

Placebo

Intervention Type DRUG

Matching oral tablet

MD-7246 1200 μg

4 MD-7246 300-μg oral tablets

Group Type EXPERIMENTAL

MD-7246

Intervention Type DRUG

Oral tablet

Placebo

4 matching placebo oral tablets

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Matching oral tablet

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MD-7246

Oral tablet

Intervention Type DRUG

Placebo

Matching oral tablet

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient meets the Rome IV criteria for diagnosis of IBS-D
* Patient maintains a minimum level of compliance with daily diary
* Female patients of childbearing potential must agree to use one of the following methods of birth control:

1. Hormonal contraception
2. Double-barrier method
3. Maintenance of a monogamous relationship with a male partner who has been surgically sterilized by vasectomy

Exclusion Criteria

* Patient has clinically significant findings on a physical examination and/or clinical laboratory tests
* Patient has symptoms of or been diagnosed with a medical condition that may contribute to abdominal pain
* Patient has a structural abnormality of the gastrointestinal (GI) tract or a disease or condition that can affect GI motility
* Patient has any protocol-excluded or clinically significant medical or surgical history that could confound the study assessments
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Allergan Sales, LLC

INDUSTRY

Sponsor Role collaborator

Ironwood Pharmaceuticals, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Wilmin Bartolini, PhD

Role: STUDY_CHAIR

Ironwood Pharmaceuticals, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Research Associates

Huntsville, Alabama, United States

Site Status

Elite Clinical Studies

Phoenix, Arizona, United States

Site Status

Arkansas Gastroenterology

North Little Rock, Arkansas, United States

Site Status

GW Research, Inc.

Chula Vista, California, United States

Site Status

Kindred Medical Institute for Clinical Trials, LLC

Corona, California, United States

Site Status

Diagnamics Inc.

Encinitas, California, United States

Site Status

St. Joseph Heritage Healthcare

Fullerton, California, United States

Site Status

Paragon Rx Clinical

Garden Grove, California, United States

Site Status

Grossmont Center For Clinical Research

La Mesa, California, United States

Site Status

Facey Medical Foundation

Mission Hills, California, United States

Site Status

Providence Clinical Research

North Hollywood, California, United States

Site Status

Precision Research Institute

San Diego, California, United States

Site Status

Paragon Rx Clinical, Inc. - Santa Ana

Santa Ana, California, United States

Site Status

UNISON Clinical Trials

Sherman Oaks, California, United States

Site Status

Millennium Clinical Trials

Thousand Oaks, California, United States

Site Status

Advanced Rx Clinical Research

Westminster, California, United States

Site Status

Peak Gastroenterology Associates

Colorado Springs, Colorado, United States

Site Status

Connecticut Clinical Research Institute

Bristol, Connecticut, United States

Site Status

Chase Medical Research of Greater New Haven LLC

Hamden, Connecticut, United States

Site Status

The Chappel Group Research, LLC

Kissimmee, Florida, United States

Site Status

Well Pharma Medical Research Corporation

Miami, Florida, United States

Site Status

New Horizon Research Center

Miami, Florida, United States

Site Status

San Marcus Research Clinic Inc

Miami Lakes, Florida, United States

Site Status

Ormond Medical Arts Pharmaceutical Research Center

Ormond Beach, Florida, United States

Site Status

Meridien Research

St. Petersburg, Florida, United States

Site Status

Palm Beach Research Center

West Palm Beach, Florida, United States

Site Status

Research Institute of Central Florida, LLC

Winter Park, Florida, United States

Site Status

Mount Vernon Clinical Research, LLC

Sandy Springs, Georgia, United States

Site Status

Rockford Gastroenterology Associates LTD

Rockford, Illinois, United States

Site Status

Clinical Trials Management LLC

Metairie, Louisiana, United States

Site Status

Clinical Trials of America -- LA LLC

West Monroe, Louisiana, United States

Site Status

Meritus Center For Clinical Research

Hagerstown, Maryland, United States

Site Status

Meridian Clinical Research

Rockville, Maryland, United States

Site Status

Boston Clinical Trials Inc

Boston, Massachusetts, United States

Site Status

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States

Site Status

New England Center For Clinical Research Inc PrimaCare Research, LLC

Fall River, Massachusetts, United States

Site Status

MedVadis Research Corporation

Watertown, Massachusetts, United States

Site Status

Galen Research

Chesterfield, Missouri, United States

Site Status

Bozeman Health Deaconess Hospital

Bozeman, Montana, United States

Site Status

Barrett Clinic, P.C. - BTC - PPDS

La Vista, Nebraska, United States

Site Status

Meridian Clinical Research

Omaha, Nebraska, United States

Site Status

Clinical Research of South Nevada

Las Vegas, Nevada, United States

Site Status

Advanced Biomedical Research of America

Las Vegas, Nevada, United States

Site Status

Healthwise Medical Associates

Brooklyn, New York, United States

Site Status

Long Island Gastrointestinal Research Group LLP

Great Neck, New York, United States

Site Status

Rochester Clinical Research, Inc

Rochester, New York, United States

Site Status

Carolina Digestive Health Associates

Charlotte, North Carolina, United States

Site Status

Carolina Digestive Health Associates

Concord, North Carolina, United States

Site Status

Peters Medical Research, LLC

High Point, North Carolina, United States

Site Status

Clinical Trials of America-NC, LLC

Mount Airy, North Carolina, United States

Site Status

M3 Wake Research, Inc

Raleigh, North Carolina, United States

Site Status

PMG Research of Wilmington

Wilmington, North Carolina, United States

Site Status

Lyndhurst Clinical Research

Winston-Salem, North Carolina, United States

Site Status

PMG Research of Winston-Salem

Winston-Salem, North Carolina, United States

Site Status

Progressive Medicine of the Triad, LLC

Winston-Salem, North Carolina, United States

Site Status

Lillestol Research

Fargo, North Dakota, United States

Site Status

Hometown Urgent Care and Research

Cincinnati, Ohio, United States

Site Status

Hightop Medical Research Center

Cincinnati, Ohio, United States

Site Status

New Horizons Clinical Research

Cincinnati, Ohio, United States

Site Status

Hometown Urgent Care and Research

Columbus, Ohio, United States

Site Status

Remington Davis Inc

Columbus, Ohio, United States

Site Status

Hometown Urgent Care and Research

Dayton, Ohio, United States

Site Status

Central Sooner Research

Norman, Oklahoma, United States

Site Status

IPS Research Company

Oklahoma City, Oklahoma, United States

Site Status

Digestive Disease Specialists, Inc.

Oklahoma City, Oklahoma, United States

Site Status

Oregon Center For Clinical Investigations Inc

Salem, Oregon, United States

Site Status

Partners In Clinical Research

Cumberland, Rhode Island, United States

Site Status

Ocean State Clinical Research Partners

Lincoln, Rhode Island, United States

Site Status

Mountain View Clinical Research Inc

Greer, South Carolina, United States

Site Status

WR-ClinSearch, LLC

Chattanooga, Tennessee, United States

Site Status

New Phase Research & Development

Knoxville, Tennessee, United States

Site Status

MW Clinical Research Center

Beaumont, Texas, United States

Site Status

Texas Tech University Health Sciences Center

El Paso, Texas, United States

Site Status

Southwest Clinical Trials

Houston, Texas, United States

Site Status

Southwest Clinical Trials

Houston, Texas, United States

Site Status

Quality Research Inc

San Antonio, Texas, United States

Site Status

Diagnostics Research Group

San Antonio, Texas, United States

Site Status

DCT - Stone Oak, LLC dba Discovery Clinical Trials

San Antonio, Texas, United States

Site Status

Advanced Research Institute

Ogden, Utah, United States

Site Status

New River Valley Research Institute

Christiansburg, Virginia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MCP-103-205

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.